
Biomedical scientist, a Whitehead Institute member from 2002 to 2021 and a Howard Hughes Medical Institute investigator from 2008 to 2021; elected to the National Academy of Sciences in 2016.
Massachusetts Institute of Technology
Whitehead Institute for Biomedical Research
A novel of Aaron Burr dictating his life, from the Revolution to his treason trial.
A novel of Lincoln's presidency seen through the eyes of the people around him.
“I tend to like historical fiction, so some of the books I've liked a lot and given to others have been Gore Vidal books. Like Lincoln or Burr. They're American history historical fiction.” — David Sabatini
Source: The Tim Ferriss Show Transcripts: Peter Attia, David Sabatini, and Navdeep Chandel (#193)
| Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D. | The Peter Attia Drive | 2023-09-25 | 2:51 | View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode of The Drive, Peter welcomes guests David Sabatini and Matt Kaeberlein, two world-leading experts on rapamycin and mTOR. David and Matt begin by telling the fascinating story of the discovery of rapamycin and its brief history as a pharmacological agent in humans. They then unravel the function of mTOR, a central regulator of numerous biological processes, and they discuss the pathways through which rapamycin exerts its potential benefits on lifespan. They touch upon initial studies that suggested rapamycin may have geroprotective effects and the ongoing research that continues to shed light on this unique molecule. Furthermore, they discuss the elusive details surrounding the frequency and dosing of rapamycin use in humans, and Peter emphasizes his reservations about indiscriminately prescribing rapamycin as a longevity drug for patients. |
| mTOR in Aging Ep4 - Rapamycin and Rapalogs | Dr David Sabatini Interview Series | Modern Healthspan | 2021-07-11 | 9 min | In this video Dr. Sabatini discusses rapamycin, how it acts on mTORC1 and mTORC2 and the rapalogs, drugs which are similar to rapamycin but may be more clinically effective. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabatini has continued to work on better understanding this complex regulator of our metabolism Some key references. Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction https://www.biorxiv.org/content/10.1101/2020.10.22.351361v1.full.pdf Twenty-five years of mTOR: Uncovering the link from nutrients to growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692607/ mTOR introduction YouTube Series with Dr. Sabatini https://www.youtube.com/watch?v=EnIerDljc7g https://www.youtube.com/watch?v=defOfBEuw_M https://www.youtube.com/watch?v=tGA9RALG66s |
| mTOR in Aging Ep2 - How mTOR Impacts Lifespan | Dr David Sabatini Interview Series | Modern Healthspan | 2021-06-28 | 9 min | Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabatini has continued to work on better understanding this complex regulator of our metabolism In this video Dr. Sabatini discusses how mTOR impacts lifespan and whether its actions change with age Some key references. Twenty-five years of mTOR: Uncovering the link from nutrients to growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692607/ mTOR introduction YouTube Series with Dr. Sabatini https://www.youtube.com/watch?v=EnIerDljc7g https://www.youtube.com/watch?v=defOfBEuw_M https://www.youtube.com/watch?v=tGA9RALG66s |
| mTOR in Aging Ep1 - The Role of mTOR | Dr David Sabatini Interview Series | Modern Healthspan | 2021-06-13 | 11 min | In this video Dr. Sabatini discusses the role of mTOR as the master regulator of the cell and distinguishes between mTORC1 and mTORC2. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabatini has continued to work on better understanding this complex regulator of our metabolism |
| Episode 70: David Sabatini on the discovery of mTOR and its role in disease, longevity & healthspan | STEM-Talk | 2018-08-14 | 1:16 | Peter Attia, who was our very first guest on STEM-Talk, describes David Sabatini’s discovery of mTOR as one of his two favorite science stories. Today, Dr. David Sabatini joins us and gives us a first-hand account of how his research into rapamycin in 1994 as a graduate student led him to the discovery of mTOR, which we now know is a critical regulator of cellular growth. Our interview with David delves into his continuing research into mTOR, which has led to promising opportunities for the development of new treatments for debilitating diseases such as cancer, diabetes and neurological disorders. He also discusses mTOR’s role in healthspan and lifespan. David is a molecular cell biologist who, according to Reuters News Service, is on the short list for a Nobel Prize. David is on the faculty at MIT and heads up the Sabatini Lab at the Whitehead Institute. |
| David Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity? | The Peter Attia Drive | 2018-08-13 | 1:11 | In this episode, my good friend David Sabatini delves into his extensive work with the mechanistic target of rapamycin—better known as mTOR—and rapamycin. The compound rapamycin is the only known pharmacological agent to extend lifespan all the way from yeast to mammals—across a billion years of evolution. David, a professor of biology and a member of the Whitehead Institute at MIT, shares his remarkable journey and discovery of mTOR in mammalian cells and its central role in nutrient sensing and longevity. Fasting, rapamycin, mTOR, autophagy, gedankenexperiments: having this conversation with David is like being the proverbial kid in the world's greatest candy store. We discuss: mTOR and David's student years [4:30]; Rapamycin and the discovery of mTOR [8:15]; The connection between rapamycin, mTOR, and longevity [30:30]; mTOR as the cell's general contractor [34:45]; The effect of glucose, insulin, and amino acids on mTORC1 [42:50]; Methionine sensing and restriction [49:45]; An intermittent approach to rapamycin [54:30]; Rapamycin's effects on cancer, cardiovascular disease, and neurodegeneration [57:00]; Gedankenexperiment: couch potatoes on rapamycin vs perfectly behaved humans [1:03:15]; David's dream experiment with no resource constraints [1:07:00]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram . |
| My Life Extension Pilgrimage to Easter Island (#193) | The Tim Ferriss Show | 2016-10-20 | ||
| 'It was horrible': Ex-MIT scientist breaks silence after $6M defamation verdict | Full interview | Boston 25 News | |||
| Storer Lectureship feat. David Sabatini, Massachusetts Institute of Technology | May 12, 2015 | UC Davis College of Biological Sciences | |||
| Signaling Pathways in Cancer Symposium: David Sabatini | KochInstituteMIT |
MmTOR in Aging Ep4 - Rapamycin and Rapalogs | Dr David Sabatini Interview SeriesModern Healthspan · 2021-07-11
MmTOR in Aging Ep2 - How mTOR Impacts Lifespan | Dr David Sabatini Interview SeriesModern Healthspan · 2021-06-28
MmTOR in Aging Ep1 - The Role of mTOR | Dr David Sabatini Interview SeriesModern Healthspan · 2021-06-13
TDavid Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity?The Peter Attia Drive · 2018-08-13
TMy Life Extension Pilgrimage to Easter Island (#193)The Tim Ferriss Show · 2016-10-20
B'It was horrible': Ex-MIT scientist breaks silence after $6M defamation verdict | Full interviewBoston 25 News
UStorer Lectureship feat. David Sabatini, Massachusetts Institute of Technology | May 12, 2015UC Davis College of Biological Sciences
KSignaling Pathways in Cancer Symposium: David SabatiniKochInstituteMIT| Inside the fall of David Sabatini Paywall | The Boston Globe | 2023 |